1H Magnetic Resonance Spectroscopy Assessment of the Effects of Rivastigmine on Patients with moderate Alzheimer Disease. VITAE. 2005;3(24). Accessed March 30, 2026. https://sosvitae.ucv.ve/index.php/vitae/article/view/391